275 related articles for article (PubMed ID: 31003562)
1. Functional Characterization of Clinically-Relevant Rare Variants in
Toyoda Y; Mančíková A; Krylov V; Morimoto K; Pavelcová K; Bohatá J; Pavelka K; Pavlíková M; Suzuki H; Matsuo H; Takada T; Stiburkova B
Cells; 2019 Apr; 8(4):. PubMed ID: 31003562
[TBL] [Abstract][Full Text] [Related]
2. Functional non-synonymous variants of ABCG2 and gout risk.
Stiburkova B; Pavelcova K; Zavada J; Petru L; Simek P; Cepek P; Pavlikova M; Matsuo H; Merriman TR; Pavelka K
Rheumatology (Oxford); 2017 Nov; 56(11):1982-1992. PubMed ID: 28968913
[TBL] [Abstract][Full Text] [Related]
3. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
[TBL] [Abstract][Full Text] [Related]
4. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K
Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout.
Wrigley R; Phipps-Green AJ; Topless RK; Major TJ; Cadzow M; Riches P; Tausche AK; Janssen M; Joosten LAB; Jansen TL; So A; Harré Hindmarsh J; Stamp LK; Dalbeth N; Merriman TR
Arthritis Res Ther; 2020 Mar; 22(1):45. PubMed ID: 32164793
[TBL] [Abstract][Full Text] [Related]
6. ABCG2/BCRP dysfunction as a major cause of gout.
Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Suzuki H; Hosoya T; Shinomiya N
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1117-28. PubMed ID: 22132966
[TBL] [Abstract][Full Text] [Related]
7. ABCG2 as a therapeutic target candidate for gout.
Fujita K; Ichida K
Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort.
Roman Y; Tiirikainen M; Prom-Wormley E
Clin Rheumatol; 2020 Aug; 39(8):2387-2392. PubMed ID: 32107664
[TBL] [Abstract][Full Text] [Related]
9. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
Torres RJ; Puig JG
Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
[TBL] [Abstract][Full Text] [Related]
10. The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people.
Yamagishi K; Tanigawa T; Kitamura A; Köttgen A; Folsom AR; Iso H;
Rheumatology (Oxford); 2010 Aug; 49(8):1461-5. PubMed ID: 20421215
[TBL] [Abstract][Full Text] [Related]
11. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
Eckenstaler R; Benndorf RA
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206432
[TBL] [Abstract][Full Text] [Related]
12. The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis.
Lukkunaprasit T; Rattanasiri S; Turongkaravee S; Suvannang N; Ingsathit A; Attia J; Thakkinstian A
BMC Med Genet; 2020 Oct; 21(1):210. PubMed ID: 33087043
[TBL] [Abstract][Full Text] [Related]
13. Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors.
Nakayama A; Matsuo H; Nakaoka H; Nakamura T; Nakashima H; Takada Y; Oikawa Y; Takada T; Sakiyama M; Shimizu S; Kawamura Y; Chiba T; Abe J; Wakai K; Kawai S; Okada R; Tamura T; Shichijo Y; Akashi A; Suzuki H; Hosoya T; Sakurai Y; Ichida K; Shinomiya N
Sci Rep; 2014 Jun; 4():5227. PubMed ID: 24909660
[TBL] [Abstract][Full Text] [Related]
14. Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects.
Takei R; Cadzow M; Markie D; Bixley M; Phipps-Green A; Major TJ; Li C; Choi HK; Li Z; Hu H; ; Guo H; He M; Shi Y; Stamp LK; Dalbeth N; Merriman TR; Wei WH
J Hum Genet; 2021 Feb; 66(2):161-169. PubMed ID: 32778763
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia.
Pálinkás M; Szabó E; Kulin A; Mózner O; Rásonyi R; Juhász P; Nagy K; Várady G; Vörös D; Zámbó B; Sarkadi B; Poór G
Clin Exp Med; 2023 Aug; 23(4):1277-1284. PubMed ID: 35939175
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of
Duong NT; Ngoc NT; Thang NTM; Phuong BTH; Nga NT; Tinh ND; Quynh DH; Ton ND; Hai NV
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30621105
[No Abstract] [Full Text] [Related]
17. Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout.
Dong Z; Zhou J; Jiang S; Li Y; Zhao D; Yang C; Ma Y; He H; Ji H; Jin L; Zou H; Wang J
Hereditas; 2020 Jan; 157(1):2. PubMed ID: 32000861
[TBL] [Abstract][Full Text] [Related]
18. Identification of ABCG2 dysfunction as a major factor contributing to gout.
Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Takada Y; Okada C; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1098-104. PubMed ID: 22132963
[TBL] [Abstract][Full Text] [Related]
19. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.
Woodward OM; Köttgen A; Coresh J; Boerwinkle E; Guggino WB; Köttgen M
Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10338-42. PubMed ID: 19506252
[TBL] [Abstract][Full Text] [Related]
20. Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.
Hurba O; Mancikova A; Krylov V; Pavlikova M; Pavelka K; Stibůrková B
PLoS One; 2014; 9(9):e107902. PubMed ID: 25268603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
